Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10487147 Anti-PD-L1 antibodies and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
March 9, 2017
Date of Patent
November 26, 2019
Patent Application Number
15454959
Patent Citations Received
US Patent 11884724 Anti-PD-L1 antibodies and uses thereof
0
US Patent 11560429 Anti PD-1 antibodies
US Patent 10864203 Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
US Patent 10981994 Anti PD-1 antibodies
US Patent 10988545 Anti-GITR antigen-binding proteins and methods of use thereof
0
US Patent 11597768 Immunotherapy for hepatocellular carcinoma
US Patent 11274154 Dosing regimen of avelumab for the treatment of cancer
0
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors
US Patent 11512132 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
0
•••
Patent Inventor Names
Mark Cartwright
0
Sean D. McKenna
0
Christel Iffland
0
Horacio G. Nastri
0
Olivier Leger
0
Qi An
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10487147
Patent Primary Examiner
Ilia I Ouspenski
Find more entities like US Patent 10487147 Anti-PD-L1 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE